Levels of LC3A/B and p62 proteins in tumor tissues were quantitatively assessed by immunohistochemistry, showing that QCT treatment significantly increased the level of LC3A/B protein and decreased the level of p62 protein in tumors compared to the control. This evidence concerns the gene MAP1LC3A and neoplasm.